Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 1,500 | $32.09 | $48.1K | -0.8% | Open the original filing on SEC.gov |
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 10,300 | $34.24 | $352.6K | -5.1% | Open the original filing on SEC.gov |
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 13,900 | $33.38 | $464K | -6.5% | Open the original filing on SEC.gov |
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 31,961 | $32.30 | $1M | -12.9% | Open the original filing on SEC.gov |
| Jan 2 | VKTX | Viking Therapeutics, Inc. | AGRANT◆ | 91,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | VKTX | Viking Therapeutics, Inc. | AGRANT | 32,049 | — | — | +14.9% | Open the original filing on SEC.gov |
| Jan 2 | VKTX | Viking Therapeutics, Inc. | AGRANT | 41,000 | — | — | +23.5% | Open the original filing on SEC.gov |
| Oct 28, 2025 | VKTX | Viking Therapeutics, Inc. | SSELL | 6,185 | $35.00 | $216.5K | -3.4% | Open the original filing on SEC.gov |
| Oct 27, 2025 | VKTX | Viking Therapeutics, Inc. | AGRANT | 11,117 | — | — | +6.6% | Open the original filing on SEC.gov |
| Jul 3, 2025 | VKTX | Viking Therapeutics, Inc. | SSELL | 4,266 | $27.76 | $118.4K | -2.5% | Open the original filing on SEC.gov |
| Jul 2, 2025 | VKTX | Viking Therapeutics, Inc. | AGRANT | 7,667 | — | — | +4.6% | Open the original filing on SEC.gov |